Fullt title: The impact of CFS/ME on employment and productivity in the UK: a cross-sectional study based on the CFS/ME National Outcomes Database
Authors: Simon M Collin , Esther Crawley , Margaret T May , Jonathan AC Sterne , William Hollingworth and Uk cfs/me National Outcomes Database
Publication: BMC Health Services Research 2011, 11:217doi:10.1186/1472-6963-11-217
Published: 15 September 2011
Few studies have investigated factors associated with discontinuation of employment in patients with CFS/ME or quantified its impact on productivity.
We used patient-level data from five NHS CFS/ME services during the period 01/04/2006-31/03/2010 collated in the UK CFS/ME National Outcomes Database. We used logistic regression to identify factors associated with discontinuation of employment. We estimated UK-wide productivity costs using patient-level data on duration of illness before assessment by a CFS/ME service, duration of unemployment, age, sex and numbers of patients, in conjunction with Office for National Statistics income and population data.
Data were available for 2,170 patients, of whom 1,669 (76.9%) were women. Current employment status was recorded for 1,991 patients (91.8%), of whom 811 patients (40.7%) were currently employed and 998 (50.1%) had discontinued their employment "because of fatigue-related symptoms". Older age, male sex, disability, fatigue, pain, and duration of illness were associated with cessation of employment. In a multivariable model, age, male sex, and disability remained as independent predictors. Total productivity costs among the 2,170 patients due to discontinuation of employment in the years preceding assessment by a specialist CFS/ME service (median duration of illness = 36 months) were GBP (£) 49.2 million.
Our sample was equivalent to 4,424 UK adults accessing specialist services each year, representing productivity costs to the UK economy of GBP102.2 million. Sensitivity analyses suggested a range between GBP75.5-GBP128.9 million.
CFS/ME incurs huge productivity costs among the small fraction of adults with CFS/ME who access specialist services.
View this abstract in BioMed.
View the provisional PDF of the complete article.